CDT Equity CDT
NASDAQ CDT
$0.40 -0.04 (-9.09%)
At close: Nov 13, 2026 · 4:00 PM EST

CDT Equity (CDT) Return on Capital Employed [ROCE] (2022 - 2026)

Updated

CDT Equity (CDT) posted Return on Capital Employed [ROCE] of -33.74% for Q2 2026, up 486.61 percentage points from -520.34% a year earlier and up 48.72 percentage points from the prior quarter.

Analysis

CDT Equity (CDT) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends

For FY2023, CDT Equity's Return on Capital Employed [ROCE] came in at -292.25%.

  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 17.52%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 21.60%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.65%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.91%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 17.37%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -6.15%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 11.32%
10 CDT Equity 426.40 -6.19 Mn - -33.74%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -33.74%
Mar 31, 2026 -82.45%
Sep 30, 2025 -477.19%
Jun 30, 2025 -520.34%
Mar 31, 2025 -1,144.08%
Dec 31, 2023 -67.77%
Sep 30, 2023 -242.83%
Dec 31, 2022 -4.90%
Sep 30, 2022 -1.09%
API Access

CDT Equity Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CDT&period=max&api_key=YOUR_API_KEY